SCHEMBL4088536

SCHEMBL4088536

O=C(c1ccc(F)cc1)c1nc2ccccc2s1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B1 P14061 2/20 0.68
HSD17B2 P37059 2/20 0.68
NPC1 O15118 6/20 0.60
RAB9A P51151 6/20 0.60
LMNA P02545 5/20 0.60
MAPT P10636 4/20 0.60
SMN1; SMN2 Q16637 4/20 0.60
MEN1 O00255 3/20 0.60
KMT2A Q03164 3/20 0.60
KDM4E B2RXH2 2/20 0.60
HTT P42858 2/20 0.60
NFKB1 P19838 2/20 0.59
NFKB2 Q00653 2/20 0.59
RELA Q04206 2/20 0.59
PDE10A Q9Y233 2/20 0.54
ALDH1A1 P00352 2/20 0.53
MCL1 Q07820 2/20 0.52
BCL2 P10415 1/20 0.52
BAD Q92934 1/20 0.52
NPSR1 Q6W5P4 2/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24751 0.87 HSD17B1 (0.62) HSD17B1HSD17B2NPC1RAB9ALMNA
SCHEMBL1304947 0.86 HSD17B1 (0.66) HSD17B1HSD17B2NPC1RAB9ALMNA
Bromide SCHEMBL28862925 0.85 HSD17B1 (0.61) HSD17B1HSD17B2NPC1RAB9ALMNA
SCHEMBL14020213 0.84 HSD17B1 (0.59) HSD17B1HSD17B2NPC1RAB9ALMNA
SCHEMBL28901460 0.84 HSD17B1 (0.60) HSD17B1HSD17B2NPC1RAB9ALMNA
SCHEMBL14020417 0.84 HSD17B1 (0.64) HSD17B1HSD17B2NPC1RAB9ALMNA
SCHEMBL11989060 0.84 HSD17B1 (0.60) HSD17B1HSD17B2NPC1RAB9ALMNA
SCHEMBL6319718 0.83 ALDH1A1 (0.66) HSD17B1HSD17B2NPC1RAB9ALMNA
SCHEMBL14020155 0.83 PDE10A (0.58) HSD17B1HSD17B2NPC1RAB9ALMNA
SCHEMBL22526 0.81 HSD17B1 (1.00) HSD17B1HSD17B2ALDH1A1MCL1BCL2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009058810-A1 PROCESS FOR THE PREPARATION OF SUBSTITUTED 2,4,5,6,7,8-HEXAHYDRO-1,2,6-TRIAZA-AZULENE DERIVATIVES JANSSEN PHARMACEUTICA N.V. (BE) 2009-05-07 WO disclosed